Literature DB >> 15804152

Cardiopulmonary bypass in patients with pre-existing coagulopathy.

William DeBois1, Junli Liu, Leonard Lee, Leonard Girardi, Wilson Ko, Anthony Tortolani, Karl Krieger, O Wayne Isom.   

Abstract

Patients with pre-existing coagulopathies who undergo surgical interventions are at increased risk for bleeding complications. This risk is especially true in cardiac surgical procedures with cardiopulmonary bypass (CPB) because of the necessity for heparinization and the use of the extracorporeal circuits, which have destructive effects on most of the blood components. In this review, cases of cardiac surgeries in patients with certain pre-existing coagulopathies are summarized, which could shed a light on future managements of such patients undergoing cardiac procedures with CPB. Pre-existing coagulopathies include antithrombin III deficiency, heparin-induced thrombocytopenia, cancer, factor XII deficiency, hemophilia, idiopathic thrombocytopenic purpura, protein S deficiency, and drug-induced platelet inhibition. In summary, pre-existing coagulopathy in patients undergoing open-heart surgeries, if not recognized and appropriately managed, can cause serious complications. Management of patients undergoing cardiac procedures should include a routine coagulation work-up and a thorough past medical history examination. If any of the foregoing is abnormal, further evaluation is warranted. Proper diagnosis and management of the pre-existing coagulopathy disorders is of crucial importance to the surgical outcome and long-term morbidity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804152      PMCID: PMC4680798     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  76 in total

1.  Fresh whole blood and immunoglobulin permit coronary artery bypass graft surgery in patients with idiopathic thrombocytopenic purpura.

Authors:  G Cetin; K Karaoğlu; S Seren; C Bakay
Journal:  J Cardiothorac Vasc Anesth       Date:  2001-08       Impact factor: 2.628

2.  Preoperative immunoglobulin treatment in patients with Werlhof's disease undergoing cardiac operation.

Authors:  S Christiansen; C Schmid; K Redmann; U R Jahn; J Stypmann; H H Scheld; D Hammel
Journal:  Ann Thorac Surg       Date:  2000-01       Impact factor: 4.330

3.  Cardiopulmonary bypass in a patient with factor XII deficiency.

Authors:  M Salmenperä; V Rasi; S Mattila
Journal:  Anesthesiology       Date:  1991-09       Impact factor: 7.892

Review 4.  Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence.

Authors:  E J Topol
Journal:  Circulation       Date:  1998-01-20       Impact factor: 29.690

5.  Congenital factor XII deficiency: successful open heart surgery and anticoagulation.

Authors:  P R Kelsey; J Bottomley; G J Grotte; J E Maciver
Journal:  Clin Lab Haematol       Date:  1985

6.  Cardiopulmonary bypass with a low-molecular-weight heparin fraction.

Authors:  M Gouault-Heilmann; Y Huet; G Contant; D Payen; G Bloch; M Rapin
Journal:  Lancet       Date:  1983-12-10       Impact factor: 79.321

7.  Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass.

Authors:  V J Zulys; S J Teasdale; E R Michel; R A Skala; S E Keating; J R Viger; M F Glynn
Journal:  Anesthesiology       Date:  1989-12       Impact factor: 7.892

8.  Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery.

Authors:  Julio C Vasquez; Anna Vichiendilokkul; Syed Mahmood; Frank A Baciewicz
Journal:  Ann Thorac Surg       Date:  2002-12       Impact factor: 4.330

9.  Acquired resistance to activated protein C in breast cancer patients.

Authors:  Marten R Nijziel; Rene van Oerle; M Christella; L G D Thomassen; Elisabeth C M van Pampus; Karly Hamulyák; Guido Tans; Jan Rosing
Journal:  Br J Haematol       Date:  2003-01       Impact factor: 6.998

10.  Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery.

Authors:  Alan F Merry
Journal:  Semin Thromb Hemost       Date:  2004-06       Impact factor: 4.180

View more
  2 in total

1.  Modifiable Risk Factors associated with Post-Operative Bleeding and transfusion requirements in Cardiac Surgery.

Authors:  Bahauddin Khan; Mujahid Ul Islam; Imtiaz Ahmad; Mujeeb Ur Rehman
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

2.  Preventative management against thromboembolism using fresh frozen plasma in a coronary artery bypass graft patient with protein S deficiency: a case report.

Authors:  Kenzaburou Sugimoto; Mamoru Kadosaki; Atsushi Egawa; Rina Tokitou; Miho Urayama; Mamoru Takeuchi
Journal:  JA Clin Rep       Date:  2018-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.